semaglutide hfpef trial Poll: Do you think we'll see new FDA approval for semaglutide, specifically or Heart Failure and/or CKD, in 2025? 💊 This post highlights primary takeaways from 2 major trials from the past ~ Heart Failure with Preserved Ejection

You may purchase additional doses after the initial program if recommended by your provider

The tirzepatide to semaglutide transition typically involves starting semaglutide at a moderate dose (0.5mg or 1.0mg weekly) rather than the standard 0.25mg starting dose, since the body is already adapted to GLP-1 receptor activation

Nasal spray or injection

This is particularly relevant in clinical settings where dose escalation is often used, raising the need for further research to clarify the safety and efficacy of prolonged treatment

It also contains a small amount of glacial acetic, sodium chloride and of course, water for the injection